Addex Therapeutics Ltd. (ADXN) Accounts Payables (2022 - 2024)

Addex Therapeutics' Accounts Payables history spans 3 years, with the latest figure at $907266.7 for Q4 2024.

  • For Q4 2024, Accounts Payables fell 18.25% year-over-year to $907266.7; the TTM value through Dec 2024 reached $907266.7, down 18.25%, while the annual FY2024 figure was $903435.6, 17.57% down from the prior year.
  • Accounts Payables for Q4 2024 was $907266.7 at Addex Therapeutics, down from $1.1 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $1.3 million in Q4 2022 and bottomed at $907266.7 in Q4 2024.
  • The 3-year median for Accounts Payables is $1.1 million (2023), against an average of $1.1 million.
  • The largest annual shift saw Accounts Payables fell 16.25% in 2023 before it fell 18.25% in 2024.
  • A 3-year view of Accounts Payables shows it stood at $1.3 million in 2022, then dropped by 16.25% to $1.1 million in 2023, then decreased by 18.25% to $907266.7 in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Accounts Payables are $907266.7 (Q4 2024), $1.1 million (Q4 2023), and $1.3 million (Q4 2022).